Atlas Trials

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Clinical trial NCT02824458 · UNKNOWN

Trial details

NCT number
NCT02824458
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors
Start date
2016-06-01
Primary completion
2023-12-01
Enrollment
246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.